U.S. Stocks Higher; Tech Rebound in Focus

Apple has reversed yesterday's post-event losses

Managing Editor
Sep 13, 2018 at 12:05 PM
facebook X logo linkedin


U.S. stocks are higher at midday, with the Dow Jones Industrial Average (DJI) surging on the back of Apple's (AAPL) rebound, following yesterday's post-event pullback. A broader tech bounce and hopes for renewed trade talks with China are also pushing indexes higher, with the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) sporting gains of their own. Meanwhile, investors continue to digest this morning's tame inflation data and brace for the impact of Hurricane Florence, which is headed for the Carolinas. Nevertheless, October-dated oil futures are down 2.3% at $68.76 per barrel, at last check.

Continue reading for more on today's market, including:

  • The surging weed stock blasted by option bears.
  • Tesla stock pulls back on another executive departure
  • Plus, the casino stock with unusual options volume; one apparel retailer's solid earnings; and the pharma concern plunging on a major trial miss.

Midday Market Stats Sept 13

Sporting unusual options volume today is Caesars Entertainment Corporation (NASDAQ:CZR). The stock is higher after reports surfaced that hedge fund HG Vora is increasing its stake in the casino stock and may be pushing for an outright sale of the company. Roughly 46,000 calls -- compared to 4,600 puts -- have been traded so far, six times the average intraday pace. The December 11 call is most active, with nearly 34,000 contracts traded, most of which were likely bought to open. Caesars Entertainment stock is up 0.5% at $10.40, at last check, but down more than 17% year-to-date.

Near the top of the New York Stock Exchange (NYSE) today is apparel stock Tailored Brands Inc (NYSE:TLRD), after the company last night reported solid second-quarter earnings. The stock has gapped 19.9% higher to $28.70, pacing to close above its 120-day moving average for the first time since mid-June. However, TLRD's momentum has stalled just below $29 -- where the equity landed after a second-quarter bear gap.

Chart of TLRD with 120MA

At the bottom of the Nasdaq today is Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), after the drug company's prostate cancer imaging agent missed its main goal in a late-stage trial. The stock has gapped 16.3% lower to trade at $6.10, representing a more than 35% drop from its early August high. PGNX has shed 30% over the past three months.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI